Compelling evidence demonstrates that hyperactivation of Ras/Raf/MEK/ERK functions as a downstream pathway of carcinostatic signals, comprising p16INK4A/Rb, p21, p27 and p53 to inhibit tumor development32–35. The gene discussed is CDKN2A; the disease is neoplasm.